Methods and compositions for reducing the immunogenicity of chimeric notch receptors

NZ797176BActive Publication Date: 2026-09-29CELL DESIGN LABS INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: NZ797176
Authority / Receiving Office: NZ · NZ
Patent Type: Patents
Current Assignee / Owner
Priority Date: 2017-09-11
Filing Date: 2018-06-19
Publication Date: 2026-09-29
Estimated Expiration: 2038-06-19

Application Information

Patent Timeline

11 Sep 2017

Priority

19 Jun 2018

Application

NZ797176

29 Sep 2026

Publication

NZ797176B

IPC: A61K35/17; A61K48/00; C07K14/705; C07K16/28

Inventors: EMTAGE, PETER; GILBERT, AMY

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Smart Images

Figure 1_ABST

Patent Text Reader

Abstract

The present invention relates to methods and compositions for reducing the immunogenicity of chimeric Notch receptors, which can be genetically engineered in cells of the monocyte / macrophage lineage for drug delivery. Specifically, the invention relates to transcription factors useful for controlling gene expression delivered to tissues by such chimeric Notch receptors. The transcriptional regulator comprises a DNA binding domain of human origin and a transactivation domain of human origin.

Need to check novelty before this filing date? Find Prior Art